Volume 20, Number 3—March 2014
Dispatch
Crimean-Congo Hemorrhagic Fever among Health Care Workers, Turkey
Aysel Kocagul Celikbas, Başak Dokuzoğuz, Nurcam Baykam, Sebnem Eren Gok, Mustafa Necati Eroğlu, Kenan Midilli, Herve Zeller, and Onder Ergonul
Table 2
Demographic features of HCWs with occupational exposure to Crimean-Conger hemorrhagic fever virus, Turkey, 2004–2011*
| Episode, outcome† | HCW age, y/sex/profession | Procedure | Transmission route | Ribavirin for postexposure prophylaxis | Ribavirin for therapy (no. d after symptom onset) | Fatal |
|---|---|---|---|---|---|---|
| Episode 1; survived, her baby died |
36/M/nurse | Wound care | Contact with surgical wound without protective equipment | No | Yes (0) | No |
| 31/F/nurse |
Intubation, aspiration |
Aerosol and droplet and contact without protective equipment |
No |
No |
No |
|
| Episode 2; died |
28/F/nurse |
Phlebotomy |
Needlestick |
No |
Yes (3) |
Yes |
| Episode 3; died |
41/M/physician | Resuscitation | Aerosol and droplet | – | Yes (0) | No |
| 26/M/physician | Nasal tamponade | Indirect contact | – | Yes (0) | No | |
| 29/M/physician |
Nasal tamponade |
Indirect contact |
– |
Yes (0) |
No |
|
| Episode 4; survived |
30/M/nurse |
Phlebotomy |
Needlestick |
No |
Yes (1) |
No |
| Episode 5; survived |
30/F/nurse |
Phlebotomy |
Needlestick |
Yes |
– |
No |
| Episode 6; survived | 24/F/physician | Phlebotomy | Needlestick | Yes | – | No |
*HCW, health care worker; –, ribavirin not necessary.
†Outcome for the index case-patient in each episode.
Page created: February 19, 2014
Page updated: February 19, 2014
Page reviewed: February 19, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.